ProShare Advisors LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$119,000
+6.2%
12,946
-18.7%
0.00%
Q4 2021$112,000
-36.7%
15,917
+2.6%
0.00%
Q3 2021$177,000
-43.1%
15,517
-20.0%
0.00%
-100.0%
Q2 2021$311,000
+6.9%
19,407
+19.1%
0.00%0.0%
Q1 2021$291,000
+40.6%
16,295
+6.1%
0.00%0.0%
Q4 2020$207,000
+46.8%
15,354
+28.0%
0.00%0.0%
Q3 2020$141,000
-23.0%
11,993
-3.4%
0.00%0.0%
Q2 2020$183,000
-51.8%
12,412
-21.1%
0.00%
-50.0%
Q4 2019$380,000
+14.8%
15,739
-8.7%
0.00%0.0%
Q3 2019$331,000
-34.7%
17,237
+0.4%
0.00%
-33.3%
Q2 2019$507,000
-44.7%
17,171
-11.1%
0.00%
-40.0%
Q1 2019$917,000
+32.7%
19,309
+0.8%
0.01%0.0%
Q4 2018$691,000
-50.7%
19,155
-16.0%
0.01%
-50.0%
Q3 2018$1,403,000
-2.4%
22,795
+7.1%
0.01%0.0%
Q2 2018$1,438,000
+21.0%
21,282
-2.9%
0.01%
+25.0%
Q1 2018$1,188,000
-19.5%
21,907
-11.3%
0.01%
-20.0%
Q4 2017$1,475,000
+33.6%
24,693
+8.7%
0.01%0.0%
Q3 2017$1,104,000
+1.7%
22,723
+10.0%
0.01%
-9.1%
Q2 2017$1,086,000
+13.4%
20,662
-2.2%
0.01%
+10.0%
Q1 2017$958,000
-5.1%
21,134
-20.8%
0.01%
-9.1%
Q4 2016$1,010,000
+34.1%
26,684
+33.8%
0.01%0.0%
Q3 2016$753,000
+88.7%
19,949
-12.1%
0.01%
+120.0%
Q2 2016$399,000
+48.9%
22,695
+3.0%
0.01%
+25.0%
Q1 2016$268,000
-54.5%
22,026
-8.9%
0.00%
-42.9%
Q4 2015$589,000
+54.2%
24,189
+12.2%
0.01%
+40.0%
Q3 2015$382,000
-5.4%
21,551
-5.9%
0.01%
-16.7%
Q2 2015$404,000
-39.8%
22,903
+7.0%
0.01%
-25.0%
Q1 2015$671,000
+26.8%
21,407
+18.0%
0.01%
+33.3%
Q4 2014$529,00018,1390.01%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders